Quantum Genomics S.A.
OTC: QNNTF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mathieu Bigois
- Employees
- 3
- Headquarters
- Paris, France
- IPO year
- 2021
- Market cap
- $7.0M
- Website
- https://www.quantum-genomics.com
Loading QNNTF…
Loading profile data…Frequently asked questions about QNNTF
What does Quantum Genomics S.A. (QNNTF) do?
Quantum Genomics S.A., a biopharmaceutical enterprise headquartered in Paris, France, was established in 2005. The company specializes in advancing therapeutic solutions for cardiovascular ailments. Its drug development efforts are anchored in the brain aminopeptidase A inhibition (BAPAI) platform, primarily targeting hypertension (high blood pr...
Where does QNNTF trade?
Quantum Genomics S.A. (QNNTF) trades on the Other OTC.
What sector is QNNTF in?
Quantum Genomics S.A. (QNNTF) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Quantum Genomics S.A.?
Mathieu Bigois is the chief executive officer of Quantum Genomics S.A. (QNNTF).
Where is Quantum Genomics S.A. headquartered?
Quantum Genomics S.A. is headquartered in France.
Does QNNTF pay a dividend?
Quantum Genomics S.A. (QNNTF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did QNNTF go public?
Quantum Genomics S.A. (QNNTF) completed its initial public offering in 2021.